Abstract:Background Rheumatoid arthritis is an autoimmune disease characterized by symmetrical small arthritis. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor are commonly used to diagnose RA[1]. However, the early diagnosis of RA is sometimes difficult, due to the heterogeneity and negative anti-CCP antibody or RF in some patients. Therefore, it is urgent to find autoantibodies with high sensitivity and specificity as diagnostic markers for RA. Objectives To screen autoantibodies of RA with high sensitivity and specificity using human proteome microarrays[2]. Methods Firstly, a case-control method was used to analyze the serum antibodies of RA patients using human proteome microarray which composed of 20,000 proteins, and identified RA-related antibodies. Then, expanded the sample size and analyzed the expression of these candidates between RA patients and healthy controls. Results The serum of five RA patients and five healthy controls were selected to detect the RA-related autoantibodies by microarray, and 25 candidates were screened. Then the IgG and IgM RA-focused microarrays composed of the 25 proteins were screened with additional cohorts of 72 RA patients and 106 healthy controls. The results of IgG protein microarray showed: (1) Expression of these 25 autoantibodies in RA patients was significantly higher than those in healthy controls (P 0.05). (3) ROC analysis showed that the combination of anti-RBPJ, anti-SH3BGR and anti-PAFAH1B3 autoantibody can be highly RA-specific biomarkers, with 66.7% sensitivity and 74.2% specificity, and the area under the curve is 0.734; meanwhile the sensitivity and specificity of the anti-CCP antibody and RF-negative RA patients diagnosis were 77.8% and 65.6%, and the area under the curve was 0.720. The results of IgM protein microarray showed: (1) Only 10 out of the 25 candidates’ expression was significantly higher in RA patients than healthy controls (P Conclusion The combination of IgG-type antibodies anti-RBPJ, anti-SH3BGR and anti-PAFAH1B3, the IgM-type antibody anti-PAFAH1B3 as well, has high sensitivity and specificity for the diagnosis of RA; especially the IgG-type autoantibody combination has great value for the diagnosis of anti-CCP and RF-negative RA patients. References [1] Silveira IG, et al. Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clinical Rheumatology, 2007. 26(11): p.1883-1889. [2] Song Q, et al. Novel Autoimmune Hepatitis-Specific Autoantigens Identified Using Protein Microarray Technology. Journal of Proteome Research, 2010. 9(1): p.30-39. Acknowledgement This work was supported by grants from the National Natural Science Foundation of China (81771774) and the Anhui Provincial Natural Science Foundation (1708085MH191) Disclosure of Interests None declared

Proteomics-Based Identification of Autoantibodies in the Sera of Healthy Chinese Individuals from Beijing

Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.

Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral Immune Response

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma.

Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis.

Development of an autoantibody panel for early detection of lung cancer in the Chinese population

AB0283 IDENTIFICATION OF NEW AUTOANTIBODIES FOR RHEUMATOID ARTHRITIS USING HUMAN PROTEOME MICROARRAYS

Autoantibody signature in hepatocellular carcinoma using seromics

Screening Hepatocellular Carcinoma Autoantibodies by Serological Proteome Analysis

Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer

A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer

Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer

Detection of Autoimmune Parameter of SARS Patients

Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer

An autoantibody profile identified by human genome-wide protein arrays in rheumatoid arthritis

Profiling Tumor-Associated Autoantibodies For The Detection Of Colon Cancer

Proteome Microarray Identifies Autoantibody Biomarkers for Diagnosis of Hepatitis B-related Hepatocellular Carcinoma.

Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer

Immunodiagnostic Value Of Combined Detection Of Autoantibodies To Tumor-Associated Antigens As Biomarkers In Pancreatic Cancer

Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray

Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by Autoantibodies